Ontology highlight
ABSTRACT: Purpose
More than 15 years have passed since the first description of the unbound brain-to-plasma partition coefficient (Kp,uu,brain) by Prof. Margareta Hammarlund-Udenaes, which was enabled by advancements in experimental methodologies including cerebral microdialysis. Since then, growing knowledge and data continue to support the notion that the unbound (free) concentration of a drug at the site of action, such as the brain, is the driving force for pharmacological responses. Towards this end, Kp,uu,brain is the key parameter to obtain unbound brain concentrations from unbound plasma concentrations.Methods
To understand the importance and impact of the Kp,uu,brain concept in contemporary drug discovery and development, a survey has been co
SUBMITTER: Loryan I
PROVIDER: S-EPMC9246790 | biostudies-literature | 2022 Jul
REPOSITORIES: biostudies-literature